9EH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Evolent Health Inc

Watchlist Manager

Watchlist

Price: 4.82 EUR -5.49% Market Closed

Market Cap: €552.7m

E	Evolent Health Inc F:9EH	US
O	Orion Oyj XMUN:OFK	FI
	Interpump Group SpA MIL:IP	IT
	Laboratorios Farmaceuticos ROVI SA OTC:LABFF	ES
C	Cobra Venture Corp XTSX:ROB	CA
E	Evonik Industries AG XBER:EVK	DE
	Compania de Distribucion Integral Logista Holdings SA MAD:LOG	ES
R	Raiffeisen Bank International AG XHAM:RAW	AT
	Global Ship Lease Inc F:37H	UK

Profitability Summary

Evolent Health Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

21%

Sustainable 3Y Average Gross Margin

19%

Declining Gross Margin

25% > 21%

Negative Operating Margin

-1%

Low 3Y Average Operating Margin

Declining Operating Margin

3% > -1%

Negative Net Margin

-31%

Negative 3Y Average Net Margin

-8%

Declining Net Margin

-5% > -31%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-1% > 0%

Negative ROE

-72%

Negative 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.